We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories

174 hedge funds and large institutions have $1.34B invested in Dr. Reddy's Laboratories in 2015 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 55 increasing their positions, 75 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.42% more ownership

Funds ownership: 82.29%84.71% (+2.4%)

16% less funds holding

Funds holding: 206174 (-32)

25% less capital invested

Capital invested by funds: $1.79B → $1.34B (-$452M)

27% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 75

40% less funds holding in top 10

Funds holding in top 10: 53 (-2)

62% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 47

97% less call options, than puts

Call options by funds: $109K | Put options by funds: $4.06M

Holders
174
Holders Change
-32
Holders Change %
-15.53%
% of All Funds
4.56%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.08%
New
18
Increased
55
Reduced
75
Closed
47
Calls
$109K
Puts
$4.06M
Net Calls
-$3.95M
Net Calls Change
-$4.78M
Name Holding Trade Value Shares
Change
Change in
Stake
AAM
101
Azzad Asset Management
Virginia
$749K +$18.2K +1,665 +2%
PAM
102
Panagora Asset Management
Massachusetts
$655K +$504K +46,055 +187%
CA
103
Commerzbank Aktiengesellschaft
Germany
$623K +$413K +37,670 +127%
TU
104
TDAM USA
Ontario, Canada
$568K -$371K -33,900 -36%
FA
105
FDx Advisors
Illinois
$563K +$7.72K +705 +1%
Fifth Third Bancorp
106
Fifth Third Bancorp
Ohio
$525K -$322K -29,420 -34%
VanEck Associates
107
VanEck Associates
New York
$489K -$580K -53,000 -50%
VOYA Investment Management
108
VOYA Investment Management
Georgia
$452K -$117K -10,715 -18%
TI
109
TT International
United Kingdom
$442K -$160K -14,625 -23%
Comerica Bank
110
Comerica Bank
Texas
$433K +$21.4K +1,950 +4%
Franklin Resources
111
Franklin Resources
California
$422K -$2.09M -191,185 -81%
WAM
112
World Asset Management
Michigan
$418K +$11.4K +1,040 +2%
Two Sigma Advisers
113
Two Sigma Advisers
New York
$417K +$493K +45,000 New
DekaBank Deutsche Girozentrale
114
DekaBank Deutsche Girozentrale
Germany
$393K +$82.1K +7,500 +21%
LCM
115
Logan Capital Management
Pennsylvania
$389K
Axa
116
Axa
France
$370K +$11K +1,000 +3%
Grantham, Mayo, Van Otterloo & Co (GMO)
117
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$356K +$131K +12,000 +45%
Creative Planning
118
Creative Planning
Kansas
$348K -$5.48K -500 -1%
CG
119
Cutler Group
California
$318K +$376K +34,350 New
AIA
120
Avalon Investment & Advisory
Texas
$317K -$234K -21,365 -38%
QI
121
QS Investors
New York
$310K
IMAS
122
ID Management A/S
Denmark
$301K -$137K -12,500 -28%
SAM
123
Symphony Asset Management
California
$294K -$167K -15,285 -32%
LNWWM
124
Laird Norton Wetherby Wealth Management
California
$279K -$47.3K -4,320 -13%
NEI
125
Northwest & Ethical Investments
Ontario, Canada
$277K -$452K -41,265 -58%

RDY Hedge Fund Activity: Q4 2015 in Review

174 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q4 2015, worth a combined $1.34B — down 25% from $1.79B a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of RDY and 18 opened new positions — a net loss of 29 holders — while 75 trimmed existing stakes and 55 added.

The largest buyer was Commonwealth Bank of Australia, adding an estimated $47.2M. The largest seller was Schroder Investment Management Group, cutting an estimated $49M.

  • 174 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q4 2015, down from 206 in Q3 2015.
  • Funds reported $1.34B of Dr. Reddy's Laboratories stock for Q4 2015, down 25% quarter-over-quarter.
  • 18 funds opened new Dr. Reddy's Laboratories positions in Q4 2015 and 47 closed out, a net change of -29 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q4 2015 was Commonwealth Bank of Australia, an estimated $47.2M added.
  • The largest Dr. Reddy's Laboratories seller in Q4 2015 was Schroder Investment Management Group, an estimated $49M sold.

Based on aggregated 13F filings for Q4 2015.